Date | Interest Coverage Ratio | Debt to Equity Ratio | Interest Expense To Sales | Inventory Turnover Ratio |
---|
CEO | Mr. Torsten Helsing |
IPO Date | March 4, 2011 |
Location | Sweden |
Headquarters | Södergatan 26 |
Employees | 7 |
Sector | Consumers Staples |
Industries |
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, an natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was incorporated in 2007 and is based in Malmö, Sweden.
Past 5 years
USD 0.53
USD 0.13
USD 3.10
USD 0.16
USD 0.25
StockViz Staff
February 4, 2025
Any question? Send us an email